Banca Mediolanum (BMED) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
4 Aug, 2026Executive summary
Net income for H1 2026 reached €555.5 million, up 16% year-over-year, driven by strong core business performance, diversified revenue streams, and organic growth.
Operating margin rose 20% to €683.8 million, with contribution margin up 14% to €1.16 billion, reflecting robust revenue growth and disciplined cost management.
Total assets hit a record €168.23 billion, up 8% since year-end 2025 and 16% year-over-year, supported by strong net inflows and market performance.
Customer base expanded to 2,089,500, with 110,000 new clients acquired and a 5% increase in the Family Banker network to 7,164.
Strategic initiatives in AI, longevity, and talent development are driving productivity and future growth.
Financial highlights
Net commission income rose 10% to €705.7 million, supported by higher management and investment management fees.
Net interest income surged 30% to €478.5 million, aided by a stronger funding base and lower funding costs.
Banking service fees climbed 29% to nearly €158 million, with certificate sales up over 70% to €1.2 billion.
General insurance gross premiums rose 13% to €129.1 million.
Cost/income ratio improved to 36.1% from 37.6% at FY 2025.
Outlook and guidance
Net inflows into managed assets expected to be around €9 billion for 2026, assuming normal market conditions.
Net interest income projected to rise 15%-18% versus 2025; 2027 NII expected to grow 5% with a 2.6% average Euribor.
Targeting a cost/income ratio of around 38% and cost of risk near 20 basis points.
Dividend per share planned to increase from the €0.80 base, with €1.25 per share for 2025 and €0.65 paid in April 2026.
Continued focus on prudence, credit quality, liquidity management, and cost control.
Latest events from Banca Mediolanum
- June net inflows reached €951 million, with strong managed asset growth and new client gains.BMED
Trading update9 Jul 2026 - Net income up 6% to €477.3M, with record assets, strong inflows, and robust capital ratios.BMED
Q2 20259 Jul 2026 - Q1 2026 net income up 13% to €276.2M, with strong asset growth and resilient inflows.BMED
Q1 20268 Jul 2026 - Record net income and €10.44B inflows drive 42% dividend hike; 2025 inflows to stay strong.BMED
Q4 20248 Jul 2026 - Net income up 18% to €674.3M, assets at €133B, CET1 at 23.4%, interim dividend approved.BMED
Q3 20242 Jun 2026 - Net income up 24% to €449.9M, CET1 at 23.7%, and managed asset inflows guidance raised.BMED
Q2 20242 Jun 2026 - Net income up 10–10.4% YoY to €243.3m, with record inflows and strong capital ratios.BMED
Q1 20252 Jun 2026 - Record net income, strong asset growth, and a 25% higher dividend highlight a standout year.BMED
Q4 20253 Feb 2026 - Net income up 8% to €726M, assets at €150.4B, and interim dividend raised to €0.60/share.BMED
Q3 20258 Nov 2025